Impact of Pharmaceutical Education on Medication Adherence
Type 2 Diabetes, Systemic Arterial Hypertension, Medication Adherence
About this trial
This is an interventional treatment trial for Type 2 Diabetes focused on measuring Pharmaceutical education, Type 2 Diabetes Mellitus, Systemic Arterial Hypertension, Medication adherence
Eligibility Criteria
Inclusion Criteria:
- Patients cared for by the internal medicine outpatient area of the OPD Nuevo Hospital Civil de Guadalajara "Dr. Juan I. Menchaca "
- 18-60 years
- Both genres
- With a diagnosis of type 2 diabetes mellitus and systemic arterial hypertension
- That they gave their consent under information
Exclusion Criteria:
- Inpatients on the day of their internal medicine outpatient appointment.
- Patients for whom pharmacological treatment was not prescribed for the treatment of DM2 and SAH.
- Patients who do not speak Spanish.
- Patients who could not or could not read.
Sites / Locations
- Hospital civil de Guadalajara "Dr. Juan I. Menchaca"
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
pharmaceutical education
control
The patients assigned to the intervention group will receive from the research pharmacist, a didactic talk (of at least 10 and up to 20 minutes), where they will be provided information about type 2 diabetes mellitus and Systemic Arterial Hypertension, causes of the disease and consequences of poor control, on its pharmacological treatments, changes in lifestyle and diet. In addition, the patient will be given an updated list of their prescribed medications on a wallet card.
Patients assigned to the control group will receive only standard care, represented by regular consultation with their prescribing physician.